Exhibit 21.1
Subsidiaries of Lisata Therapeutics, Inc.
| | | | | | | | | | | | | | |
| Entity | | Percentage of Ownership | | Location |
| Amorcyte, LLC | | 100% | | United States of America |
| Athelos Corporation (1) | | 99% | | United States of America |
| Cend Therapeutics, Inc. | | 100% | | United States of America |
| NeoStem Oncology, LLC | | 100% | | United States of America |
| Lisata Therapeutics Australia Pty Ltd | | 100% | | Australia |
| Lisata Therapeutics Ireland Limited | | 100% | | Ireland |
| Lisata Therapeutics KK | | 100% | | Japan |
| Lisata Therapeutics (U.K.) Limited | | 100% | | United Kingdom |
| | | | |
(1) As of December 31, 2022, Becton Dickinson's ownership interest in Athelos Corporation was 1.0%.